Literature DB >> 8661387

Conservation of a hairpin ribozyme sequence in HIV-1 is required for efficient viral replication.

O Yamada1, G Kraus, B Sargueil, Q Yu, J M Burke, F Wong-Staal.   

Abstract

We have previously described a hairpin ribozyme that targets a highly conserved sequence in the U5 region of HIV-1. To determine if escape mutations would compromise virus replication, we introduced critical mutations into the ribozyme target site of an infectious molecular clone of HIV-1MN. HIV-1 MNA has a substitution of A for G immediately 3' to the cleavage site and HIV-1 MNGC has two substitutions in the flanking sequences that are complementary to the ribozyme. In vitro studies confirmed that neither the MNA-nor the MNGC-mutated target sequence was cleaved by the ribozyme, and furthermore, the MNGC-mutated target sequence failed to bind the ribozyme. Compensatory GC substitutions in the substrate recognition domain of the ribozyme resulted in a switch of binding and cleavage specificity. Replication of both the MNA and MNGC mutant viruses was initially two to three logs lower than that of wild-type virus, but after 3 weeks, virus production rose sharply in both cultures. Nucleotide sequence of RT-PCR-amplified viral sequences obtained from virus produced at later time points revealed complete reversion of MNA or partial reversion of MNGC to wild-type genotypes. No additional mutations within the ribozyme target sequence were observed. These results indicate that mutations in this conserved ribozyme target sequence led to significant attenuation of HIV-1MN.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8661387     DOI: 10.1006/viro.1996.0324

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  4 in total

1.  Intracellular RNA cleavage by the hairpin ribozyme.

Authors:  A A Seyhan; J Amaral; J M Burke
Journal:  Nucleic Acids Res       Date:  1998-08-01       Impact factor: 16.971

2.  Sequence-specific binding of human immunodeficiency virus type 1 nucleocapsid protein to short oligonucleotides.

Authors:  R J Fisher; A Rein; M Fivash; M A Urbaneja; J R Casas-Finet; M Medaglia; L E Henderson
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

3.  Inhibition of viral replication by ribozyme: mutational analysis of the site and mechanism of antiviral activity.

Authors:  Zhenxi Zhang; John M Burke
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  Complex interactions of HIV-1 nucleocapsid protein with oligonucleotides.

Authors:  Robert J Fisher; Matthew J Fivash; Andrew G Stephen; Nathan A Hagan; Shilpa R Shenoy; Maxine V Medaglia; Lindsey R Smith; Karen M Worthy; John T Simpson; Robert Shoemaker; Karen L McNitt; Donald G Johnson; Catherine V Hixson; Robert J Gorelick; Daniele Fabris; Louis E Henderson; Alan Rein
Journal:  Nucleic Acids Res       Date:  2006-01-24       Impact factor: 16.971

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.